Medicare Coverage: HCFA/Industry Progress On Timelines, Differ On Appeals
This article was originally published in The Gray Sheet
Executive SummaryIn attempting to resolve differences on redesigning the Medicare coverage process, the Health Care Financing Administration and the medical device industry appear furthest apart on the extent of a manufacturer's ability to appeal a coverage decision.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.